Product Datasheet  
ANGPTL4 Antibody  
Catalog Number: 32550  
Technical:tech@swbio.com  
Information:info@swbio.com  
Description  
  • host_species：  
  • Rabbit
  • Amount：  
  • 100μgμg
  • Swiss-Prot No.：  
  • Swiss-Prot:Q9BY76
    NCBI Gene ID:51129
  • Form of Antibody：  
  • Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
  • Storage：  
  • Store at -20˚C
  • Immunogen：  
  • A synthesized peptide derived from human ANGPTL4
  • reactivity：  
  • Hu Ms Rt
  • appl_detail：  

  • Western blotting: 1:500 - 1:2000
    Immunohistochemistry: 1:50 - 1:200
     

  • other_names：  
  • NL2; ARP4; FIAF; HARP; PGAR
  • Purification：  
  • Antibodies were purified by affinity purification using immunogen.
  • Specificity：  
  • The antibody detects endogenous level of total ANGPTL4 protein.
  • Applications：  
  • WB IHC
  • Background：  

  • This gene encodes a glycosylated, secreted protein containing a C-terminal fibrinogen domain. The encoded protein is induced by peroxisome proliferation activators and functions as a serum hormone that regulates glucose homeostasis, lipid metabolism, and insulin sensitivity. This protein can also act as an apoptosis survival factor for vascular endothelial cells and can prevent metastasis by inhibiting vascular growth and tumor cell invasion. The C-terminal domain may be proteolytically-cleaved from the full-length secreted protein. Decreased expression of this gene has been associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. This gene was previously referred to as ANGPTL2 but has been renamed ANGPTL4.




 
© Signalway Biotechnology All Rights Reserved.